In addition, COL1A1 has been identified as an oncogene that is involved in the carcinogenesis of colorectal cancer, gastric cancer (GC), and oral cancer and could be used as a potential therapeutic target (Li et al., 2016; He et al., 2018; Zhang et al., 2018). Here, COL1A1 is linked to colorectal cancer.